Guerra Pan Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$277K Buy
9,413
+630
+7% +$16.8K 0.16% 95
2026
Q2
$211K Hold
8,783
– – 0.12% 112
2026
Q1
$247K Hold
8,783
– – 0.15% 102
2025
Q4
$219K Hold
8,783
– – 0.13% 105
2025
Q3
$224K Hold
8,783
– – 0.14% 106
2025
Q2
$213K Hold
8,783
– – 0.14% 108
2025
Q1
$223K Hold
8,783
– – 0.17% 98
2024
Q4
$233K Hold
8,783
– – 0.17% 99
2024
Q3
$254K Hold
8,783
– – 0.2% 91
2024
Q2
$246K Hold
8,783
– – 0.21% 91
2024
Q1
$244K Sell
8,783
-728
-8% -$20.2K 0.23% 89
2023
Q4
$274K Sell
9,511
-640
-6% -$19.3K 0.26% 87
2023
Q3
$337K Sell
10,151
-1,680
-14% -$59.4K 0.39% 62
2023
Q2
$434K Sell
11,831
-300
-2% -$11.7K 0.48% 57
2023
Q1
$495K Buy
12,131
+140
+1% +$6.05K 0.62% 53
2022
Q4
$614K Hold
11,991
– – 0.84% 42
2022
Q3
$507K Buy
11,991
+162
+1% +$7.87K 0.74% 49
2022
Q2
$597K Hold
11,829
– – 0.74% 47
2022
Q1
$588K Buy
11,829
+500
+4% +$25.9K 0.71% 48
2021
Q4
$669K Buy
+11,329
New +$561K 0.66% 47

Other funds holding PFE

Guerra Pan Advisors's PFE Position: Q3 2026 in Review

Guerra Pan Advisors increased its Pfizer (PFE) stake by 7.2% in Q3 2026, buying an estimated $16.8K and bringing the position to 9,413 shares worth $277K. The position accounts for 0.16% of the portfolio, ranked #95.

Guerra Pan Advisors first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $669K in Q4 2021. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Guerra Pan Advisors held 9,413 shares of Pfizer worth $277K as of Q3 2026.
  • Guerra Pan Advisors bought 630 Pfizer shares in Q3 2026, an estimated $16.8K.
  • Pfizer made up 0.16% of Guerra Pan Advisors's portfolio in Q3 2026, its #95 holding.
  • Guerra Pan Advisors first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
  • Guerra Pan Advisors's Pfizer position peaked at $669K in Q4 2021.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Guerra Pan Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.